M10.242
Drug-induced gout, left hand
Clinical Classification Guidelines
Medical Intelligence & Overview
Drug-induced gout is a form of gout that occurs as a result of medication use. Gout is a type of inflammatory arthritis characterized by sudden, severe attacks of pain, redness, and swelling in the joints. When medications trigger this condition, it can specifically affect joints such as those in the left hand, leading to discomfort and swelling. The ICD-10 code M10.242 categorizes cases where gout in the left hand results from medication effects. Recognizing this condition is important for managing and adjusting treatments to prevent recurrent episodes and joint damage.
Causes & Symptoms
Clinical Causes: Use of medications that increase uric acid levels in the blood, such as diuretics (water pills). Certain medications used for chemotherapy, which can alter uric acid metabolism. Medications containing cytotoxic agents that disrupt normal uric acid clearance. High doses or prolonged use of medications like aspirin, particularly when used in low doses. Use of drugs that impact kidney function, decreasing their ability to eliminate uric acid.
Key Symptoms: Sudden onset of intense pain in the affected joint, often awakening the patient at night. Swelling and inflammation in the joint, typically the first joint involved is the big toe, but in this case, the left hand. Redness and warmth over the affected area. Limited range of motion in the affected finger or hand. Fever or chills may occur in some cases due to joint inflammation. The symptoms may recur intermittently if the underlying cause is not addressed.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of drug-induced gout involves a combination of clinical evaluation, medical history, and laboratory tests. Key diagnostic steps include: - Reviewing recent medication history to identify drugs that may trigger gout. - Physical examination to assess joint swelling, redness, and tenderness. - Blood tests to measure uric acid levels, which may be elevated during attacks. - Joint fluid analysis via arthrocentesis to detect uric acid crystals under a microscope. - Imaging studies such as ultrasound or X-rays may be used to assess joint damage or check for crystal deposits. - Differentiating gout from other forms of arthritis, such as rheumatoid arthritis or pseudogout, through lab and clinical features. The primary focus is to identify medication triggers and confirm the presence of monosodium urate crystals in the joint fluid.
Treatment Protocols: Managing drug-induced gout involves multiple approaches: - Discontinuing or adjusting medications suspected to cause elevated uric acid levels. - Administering anti-inflammatory drugs such as nonsteroidal anti-inflammatory drugs (NSAIDs) during acute attacks. - Using colchicine or corticosteroids to reduce joint inflammation, especially if NSAIDs are contraindicated. - Implementing lifestyle changes, including dietary modifications to lower purine intake. - Monitoring uric acid levels regularly to evaluate treatment effectiveness. - Preventive measures, which may include medications like urate-lowering therapy, if attacks recur frequently. - In some cases, collaborating with healthcare providers to redesign treatment plans that account for the patient's overall health needs. It’s important to work closely with a healthcare professional to develop a tailored management plan, especially given the medication-related nature of the condition.
Clinical Advice & FAQs
Billing Guidance
Is M10.242 a billable ICD-10 code?
Yes, M10.242 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M10.242?
Clinical documentation must specify the nature of Drug-induced gout, left hand and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
